Skip to main content
All lobbying clients

IPSEN BIOPHARMACEUTICALS, INC.

Lobbying client · New Jersey · filed 2025 to 2026

Biopharmaceutical company.

$530,000 Reported spend
23 Filings counted
4 Outside firms hired
4 Bills named

Spend is reported income plus in-house expenses across 23 filings. The LDA keeps a separate client record for every registrant that files for a client, so this page adds up 4 records, one per registrant listed below. Records are combined when the client name matches once case, punctuation and endings such as Inc. or LLC are set aside; for a city, county or port the state has to match as well.

 Who filed for this client 4

Spend per registrant: fees an outside firm reported, or the costs the client reported for lobbying in-house. The rows add up to the total above.

 Bills named in these filings 4
  • H.R. 842
    Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act
    2 filings
  • S. 339
    Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act
    2 filings
  • H.R. 1
    One Big Beautiful Bill Act
    1 filing
  • H.R. 5376
    Impacts and Outcomes for Health Career Training Act
    1 filing
 Reported by year 2 years
  • 2026 $210,000 9 filings
  • 2025 $320,000 14 filings
 Issues lobbied 3

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

 Agencies and chambers lobbied 3
  • HOUSE OF REPRESENTATIVES 15
  • SENATE 15
  • Natl Economic Council (NEC) 1
 Recent filings 23 total
Q3 report
W STRATEGIES, LLC
3rd Quarter 2026 (July 1 - Sep 30) · $20,000 income · posted Oct 19, 2026
View → Q3 report
CAPITOL COUNSEL LLC
3rd Quarter 2026 (July 1 - Sep 30) · House · Senate · $30,000 income · posted Oct 19, 2026
View → Q3 report
HOLLAND & KNIGHT LLP
3rd Quarter 2026 (July 1 - Sep 30) · House · Senate · $20,000 income · posted Oct 7, 2026
View → Q2 report
W STRATEGIES, LLC
2nd Quarter 2026 (Apr 1 - June 30) · $20,000 income · posted Jul 20, 2026
View → Q2 report
CAPITOL COUNSEL LLC
2nd Quarter 2026 (Apr 1 - June 30) · House · Senate · $30,000 income · posted Jul 16, 2026
View → Q2 report
HOLLAND & KNIGHT LLP
2nd Quarter 2026 (Apr 1 - June 30) · House · Senate · $20,000 income · posted Jul 10, 2026
View → Q1 report
CAPITOL COUNSEL LLC
1st Quarter 2026 (Jan 1 - Mar 31) · House · Senate · $30,000 income · posted Apr 19, 2026
View → Q1 report
W STRATEGIES, LLC
1st Quarter 2026 (Jan 1 - Mar 31) · $20,000 income · posted Apr 18, 2026
View → Q1 report
HOLLAND & KNIGHT LLP
1st Quarter 2026 (Jan 1 - Mar 31) · House · Senate · $20,000 income · posted Apr 10, 2026
View → Q4 report
W STRATEGIES, LLC
4th Quarter 2025 (Oct 1 - Dec 31) · $20,000 income · posted Jan 20, 2026
View → Q4 report
CAPITOL COUNSEL LLC
4th Quarter 2025 (Oct 1 - Dec 31) · House · Senate · $30,000 income · posted Jan 18, 2026
View → Q4 report
HOLLAND & KNIGHT LLP
4th Quarter 2025 (Oct 1 - Dec 31) · House · Senate · $20,000 income · posted Jan 13, 2026
View → Q3 report
W STRATEGIES, LLC
3rd Quarter 2025 (July 1 - Sep 30) · $20,000 income · posted Oct 20, 2025
View → Q3 report
CAPITOL COUNSEL LLC
3rd Quarter 2025 (July 1 - Sep 30) · House · Senate · $30,000 income · posted Oct 17, 2025
View → Q3 report
HOLLAND & KNIGHT LLP
3rd Quarter 2025 (July 1 - Sep 30) · House · Senate · $20,000 income · posted Oct 15, 2025
View → Q2 report
CAPITOL COUNSEL LLC
2nd Quarter 2025 (Apr 1 - June 30) · House · Senate · $30,000 income · posted Jul 21, 2025
View → Q2 termination
RICCHETTI INCORPORATED
2nd Quarter 2025 (Apr 1 - June 30) · House · Senate · $20,000 income · posted Jul 21, 2025
View → Q2 report
W STRATEGIES, LLC
2nd Quarter 2025 (Apr 1 - June 30) · $20,000 income · posted Jul 18, 2025
View → Q2 report
HOLLAND & KNIGHT LLP
2nd Quarter 2025 (Apr 1 - June 30) · House · Senate · $20,000 income · posted Jul 13, 2025
View → Q1 report
CAPITOL COUNSEL LLC
1st Quarter 2025 (Jan 1 - Mar 31) · House · Senate · $30,000 income · posted Apr 21, 2025
View →

Showing the 20 most recent of 23 filings. Search the explorer for "IPSEN BIOPHARMACEUTICALS, INC.".

Keep going

Filings through , the newest posted date on this record. Source: federal Lobbying Disclosure Act filings, synced daily. Money is self-reported by the filer and often rounded. Lobbying is legal, disclosed activity.

Report a problem